NewsDialy
Rare disease, in the medical sense, means a condition affecting so few patients that conventional drug development produces few or no approved treatments for it.
Families who receive a genetic diagnosis for such a condition often have a molecular answer and nowhere to take it.
Nome, a startup, is trying to address that by using AI alongside drug-development expertise to help those families find potential paths toward custom treatment.
The word "custom" in Nome's framing signals something specific. The treatment paths the company maps are built around a particular family's genetic profile.
Keep reading